Business development in 2022: successful despite obstacles

Greiner Bio-One looks back on a positive business year, with the turnover of 693 million euros exceeding expectations.

Kremsmünster, May 2023 – The year’s geopolitical events stirred up uncertainty and unrest in the global markets and had an additional negative impact on supply chains which had already been disrupted due to the COVID-19 pandemic. However, orders for some product groups – such as blood collection tubes, safety products and HTS plates – went up significantly.